+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Radiopharmaceutical"

From
Global Nuclear Medicine Market 2023-2027 - Product Thumbnail Image

Global Nuclear Medicine Market 2023-2027

  • Report
  • March 2023
  • 169 Pages
  • Global
From
From
From
From
From
From
From
From
From
Global Nuclear Medicine Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Global Nuclear Medicine Market - Forecasts from 2022 to 2027

  • Report
  • March 2022
  • 124 Pages
  • Global
From
From
2022 U.S Nuclear Medicine Market Outlook Report - Product Thumbnail Image

2022 U.S Nuclear Medicine Market Outlook Report

  • Report
  • June 2022
  • 140 Pages
  • United States
Loading Indicator

Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect. The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals. Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more